Blog
Ongoing Clinical Trial: A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)
This study aims to investigate dostarlimab therapy in patients with locally advanced mismatch-repair deficient (dMMR) / microsatellite instability high (MSI-H) rectal cancer who have not received any previous treatment. Patients who achieve a complete clinical response (no detectable tumour remains)...
Talk Therapy – Have you heard about it?
If you have been diagnosed with cancer, it is likely that you have heard of a few different medical therapies....
Where is your stress coming from?
Author: Carly Fleming, Registered Psychotherapist, Everwell Counselling (everwellcounselling.ca) Stress is a reality for all of us. There is no way...
Does colon tumour location play a role in metastasis and survival?
October 2023 Colorectal cancer, the third most common cancer worldwide, can present differently depending on where it develops within the...
Gut Microbiome Variations and Colorectal Cancer Risk
October 2023 Recent findings presented at United European Gastroenterology Week demonstrated that patients with precancerous colorectal tumours showed significant variations...
Impact of Cancer on the Family: Coping and Supporting Each Other Through a Colorectal Cancer Diagnosis
A colorectal cancer diagnosis is life-changing and affects not only the patient, but also the entire family. Having a solid...
